Details of the Drug
General Information of Drug (ID: DM0E5FH)
Drug Name |
1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4,4'-Dichlorobenzil; 3457-46-3; 1,2-bis(4-chlorophenyl)ethane-1,2-dione; 4,4'-Dichlorodibenzoyl; BIS(4-CHLOROPHENYL)ETHANEDIONE; 1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione; Ethanedione, bis(4-chlorophenyl)-; Bis(p-chlorophenyl)ethanedione; 1,2-bis(4-chlorophenyl)-1,2-ethanedione; bis(4-chlorophenyl)ethane-1,2-dione; 88372-92-3; 1,2-Ethanedione, 1,2-bis(4-chlorophenyl)-; Benzil, 4,4'-dichloro-; dichlorbenzil; C14H8Cl2O2; NSC274; NSC 274; EINECS 222-387-7; PubChem3923; p-p'-Dichloro-benzil; Benzil,4'-dichloro-; 4,4'-Dichloro benz
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 279.1 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||